Cannara Biotech (LOVE) Planet MicroCap Showcase: TORONTO 2025 summary

Company overview and operations

• Operates two major facilities in Quebec: a 625,000 sq ft indoor site and a 1 million sq ft hybrid greenhouse, both acquired at significant discounts to construction cost.

• Achieves profitability and positive free cash flow, distinguishing itself among Canadian cannabis producers.

• Current production run rate is 50,000 kg per year, with the ability to double capacity organically using existing infrastructure.

• Farnham facility also generates $4 million annually from leasing space to non-cannabis tenants, reinvested into business growth.

• Valleyfield facility is 50% activated, with 12 of 24 rooms operational, targeting 100,000 kg annual output and $300 million net revenue at full scale.

Leadership and team

• CFO has a hands-on role, overseeing finance, product creation, branding, and sales, leveraging a comprehensive understanding of the business.

• CEO is highly involved, having learned cannabis cultivation firsthand and developed all SOPs, ensuring operational consistency.

• CTO has built a proprietary IT system for automated cultivation, minimizing manual labor and optimizing efficiency.

• Executive team combines expertise in finance, cultivation, and technology, supporting scalable growth.

Competitive advantages

• Proprietary genetics program and in-house R&D drive product differentiation and innovation, despite short-term revenue trade-offs.

• Strategic location in Quebec provides access to low-cost electricity and labor, reducing cultivation costs.

• Quebec’s restrictive marketing environment fosters strong brand loyalty and repeat purchases, with the company holding a 13% provincial market share.

• Three organic brands generate over $100 million in revenue, with two brands accounting for the majority.

• Upcoming launch of vapes in Quebec is expected to add 15%-20% to provincial revenue, with five SKUs accepted for sale.